Here we go...IMSC is launching the new QS=B220 tomorrow at FPED show!!!
WILMINGTON, MA--(Marketwire - 05/16/11) - In a move to further accelerate revenue growth and market penetration, Implant Sciences Corporation (OTCQB: IMSC) (Pinksheets:IMSC - News), a high technology supplier of systems and sensors for homeland security markets, today announced the launch of its new bench-top explosives and narcotics trace detector, the Quantum Sniffer™ QS-B220. Implant Sciences has already gained significant market traction with its portable explosives trace detector (ETD), the Quantum Sniffer QS-H150, which has sold over 1,300 units worldwide, totaling over $30 million in sales.
The QS-B220 is a user-friendly, low maintenance system that offers compelling economics for purchasers. It contains no radioactive materials, eliminating licensing, annual testing, and end-of-life disposal issues. A built-in automatic calibration system requires no user intervention or expensive disposables. And the QS-B220's rapid clear-down design increases operational availability and improves checkpoint throughput.
Building upon the field-tested core technology of the Quantum Sniffer QS-H150, the QS-B220 has been engineered to meet the needs of a wide range of security applications, including the requirements of the U.S. Transportation Security Administration (TSA). The system features one of the smallest footprints in the industry, making it ideal for crowded security checkpoints at airports and air cargo screening facilities. Able to detect a very wide variety of trace substances, including both narcotics and explosives, it opens new market opportunities for Implant Sciences such as prisons and border crossings.
The QS-B220 will be launched at FPED VIII, the Force Protection Equipment Demonstration, being held in Stafford Virginia, from May 17th -19th. The event, sponsored by the Department of Defense and Department of Energy, will provide Implant Sciences a venue for presenting its products and technology to the key federal, state and local decision makers in the purchase of security equipment.
Implant Sciences will sell the QS-B220 through its growing global network of 32 distributors on 6 continents.
"The QS-B220 is poised to fill a market need for a bench-top ETD that offers the same advantages as our portable QS-H150, as well as some new innovations. We anticipate that the QS-B220 will help drive increasing revenues through our expanding sales channels," stated Implant Sciences CEO, Glenn Bolduc.
Todd Silvestri, Vice President of Product Development concluded, "Implant Sciences is one of today's true innovators in trace detection. We are continuously developing new products and technologies that will help our customers increase security in a variety of applications."
AI
